-
"Diversity, Equity and Inclusion" Page Renewal
Introducing Eisai DE&I: Now and the Future
Learn more
"Diversity, Equity and Inclusion" Page Renewal
Introducing Eisai DE&I: Now and the Future
-
Looking Back on 10 Years Since the Commencement of Free Provision of DEC Tablets
Eisai Staff in Charge Talks About Overcoming Challenges on the Uneven Road by Building Trust in Global Partnerships
-
Scientists Discuss the Development of a New Treatment for the Elimination of Mycetoma
-
New Innovation Page Launch
-
September 12, 2024
-
September 5, 2024
EISAI ACCELERATES PROGRESS IN ONCOLOGY RESEARCH WITH NEW DATA AT ESMO CONGRESS 2024
-
September 2, 2024
-
August 27, 2024
RELEASE OF INSOMNIA AWARENESS VIDEO FOR JAPAN’S AUTUMN SLEEP HEALTH WEEKS
-
August 22, 2024
-
August 5, 2024
-
August 2, 2024
IR “First Quarter Financial Report for the Fiscal Year Ending March 31, 2025”
-
July 31, 2024
IR "Presentation Materials at The Alzheimer’s Association International Conference (AAIC) 2024"
-
July 11, 2024
-
July 3, 2024
-
June 21, 2024
Notification Regarding Revision of “Eisai Global Code of Conduct for Business Partners”
-
June 3, 2024
The Naito Museum of Pharmaceutical Science and Industry Listed as “Registered Museum”
-
April 8, 2024
-
October 13, 2023
-
March 9, 2023
Warning Against Solicitation, Fraudulent Emails, etc. that Use the Name of Eisai or Related Parties
Sustainability
30 countries 2.36 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of June 2024)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
